4//SEC Filing
Wellinghoff Darryl 4
Accession 0000920465-20-000043
CIK 0000920465other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:13 PM ET
Size
7.0 KB
Accession
0000920465-20-000043
Insider Transaction Report
Form 4
Wellinghoff Darryl
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-13+483→ 483 totalExercise: $4.00Exp: 2030-03-13→ Common Stock (483 underlying) - Award
Common Stock
2020-03-13$3.40/sh+483$1,642→ 9,011 total
Footnotes (2)
- [F1]These shares were acquired on 03/13/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001770350
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:13 PM ET
- Size
- 7.0 KB